Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Hydrochlorothiazide and the Risk of Skin Cancer

NCT04334824 is registered in ClinicalTrials.gov with Canadian Network for Observational Drug Effect Studies, CNODES as lead sponsor.

NCT NCT04334824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04334824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Hydrochlorothiazide and the Risk of Skin Cancer
Lead sponsor
Canadian Network for Observational Drug Effect Studies, CNODES
Phase
Observational
Overall status
Completed
Start date
May 27, 2019
Completion date
March 5, 2021
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, melanoma, non-melanoma skin cancer